FGP
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
(+2.4%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267
Avg Time Held Equity + Options
0.3
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Miscellaneous | 12.72% |
| 4 | Industrials | 12.27% |
| 5 | Healthcare | 11.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
451
Leidos
LDOS
$15B
| $1.12M | 0.01% |
7,208
-73,335
| -91% | -$13.2M |
2025 Q3
2 quarters
|
|
452
Zoetis
ZTS
$31.3B
| $1.12M | 0.01% |
9,476
-22,795
| -71% | -$2.82M |
2025 Q4
1 quarter
|
|
453
CarGurus
CARG
$2.66B
| $1.12M | 0.01% |
+32,814
| New | +$1.07M |
2026 Q1
0 quarters
|
|
454
Quest Diagnostics
DGX
$25.7B
| $1.12M | 0.01% |
5,690
-303,524
| -98% | -$59M |
2025 Q4
1 quarter
|
|
455
Carnival Corporation Ltd
CCL
$34.8B
| $1.11M | 0.01% |
43,035
+4,144
| +11% | +$121K |
2025 Q4
1 quarter
|
|
456
Essent Group
ESNT
$5.65B
| $1.1M | 0.01% |
+18,853
| New | +$1.15M |
2026 Q1
0 quarters
|
|
457
ScottsMiracle-Gro
SMG
$2.9B
| $1.1M | 0.01% |
+18,068
| New | +$1.17M |
2026 Q1
0 quarters
|
|
458
PennyMac Financial
PFSI
$3B
| $1.08M | 0.01% |
+12,386
| New | +$1.33M |
2026 Q1
0 quarters
|
|
459
Academy Sports + Outdoors
ASO
$3.42B
| $1.08M | 0.01% |
+19,171
| New | +$1.09M |
2026 Q1
0 quarters
|
|
460
American Electric Power
AEP
$68.6B
| $1.07M | 0.01% |
8,193
-221
| -3% | -$27.7K |
2025 Q3
2 quarters
|
|
461
United Therapeutics
UTHR
$23.2B
| $1.07M | 0.01% |
1,807
+384
| +27% | +$191K |
2025 Q4
1 quarter
|
|
462
UFP Industries
UFPI
$4.16B
| $1.07M | 0.01% |
11,598
-1,420
| -11% | -$144K |
2025 Q3
2 quarters
|
|
463
Invitation Homes
INVH
$15.7B
| $1.06M | 0.01% |
42,691
-956,321
| -96% | -$25M |
2025 Q2
3 quarters
|
|
464
PTC Therapeutics
PTCT
$4.96B
| $1.06M | 0.01% |
+15,500
| New | +$1.1M |
2026 Q1
0 quarters
|
|
465
Apple Hospitality REIT
APLE
$3.86B
| $1.05M | 0.01% |
91,610
+15,281
| +20% | +$185K |
2025 Q1
4 quarters
|
|
466
Fox Class B
FOX
$23.3B
| $1.05M | 0.01% |
+19,764
| New | +$1.14M |
2026 Q1
0 quarters
|
|
467
Acadia Pharmaceuticals
ACAD
$3.31B
| $1.03M | 0.01% |
+46,443
| New | +$1.11M |
2026 Q1
0 quarters
|
|
468
Ryman Hospitality Properties
RHP
$8.46B
| $1.03M | 0.01% |
11,184
+7,236
| +183% | +$694K |
2025 Q1
4 quarters
|
|
469
LegalZoom.com
LZ
$1.02B
| $1.03M | 0.01% |
180,926
+162,485
| +881% | +$1.23M |
2025 Q4
1 quarter
|
|
470
Extreme Networks
EXTR
$2.96B
| $1.03M | 0.01% |
68,007
+44,287
| +187% | +$661K |
2025 Q4
1 quarter
|
|
471
LXP Industrial Trust
LXP
$3.6B
| $1.02M | 0.01% |
22,150
+12,109
| +121% | +$592K |
2025 Q4
1 quarter
|
|
472
Northern Oil and Gas
NOG
$2.8B
| $1.02M | 0.01% |
+34,895
| New | +$903K |
2026 Q1
0 quarters
|
|
473
Applied Industrial Technologies
AIT
$12.3B
| $1.01M | 0.01% |
3,823
+1,205
| +46% | +$328K |
2025 Q4
1 quarter
|
|
474
Knowles
KN
$2.97B
| $1.01M | 0.01% |
39,409
-2,115
| -5% | -$53.5K |
2025 Q4
1 quarter
|
|
475
American Homes 4 Rent
AMH
$11B
| $1.01M | 0.01% |
36,195
-1,114,126
| -97% | -$33.7M |
2025 Q3
2 quarters
|
|
Similar funds
ECM
MIFH
GF
AIM
OTPPB
AA
IWC
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.